Results 311 to 320 of about 2,472,817 (358)

Hypoxia and oxidative stress in breast cancer Hypoxia signalling pathways [PDF]

AL Kung, BH Jiang, BL Ebert, C Chen, CC Wykoff, DE Richard, DE Richard, GL Semenza, GL Wang, GL Wang, GU Dachs, H Shim, H Zhong, H Zhong, HE Ryan, HE Ryan, JF O'Rourke, K Talks, LE Huang, M Hockel, M Ivan, M Volm, ME Cockman, NM Mazure, P Birner, P Carmeliet, P Jaakkola, PH Maxwell, PH Maxwell, PH Maxwell, PJ Ratcliffe, R Ravi, S Salceda, W Zundel, Z Arany   +34 more
core   +1 more source

Hsa-circVIM regulates breast cancer tumor progression and tamoxifen sensitivity by sponging miR-1294 in hormone receptor-positive breast cancer cells. [PDF]

Discov Oncol
Chen Y, Zhang Z, Luo X, Cen M, Dai P, Zhu X.   +5 more
europepmc   +1 more source

Synthetic Strategy for mRNA Encapsulation and Gene Delivery with Nanoscale Metal‐Organic Frameworks

Advanced Functional Materials, EarlyView.
This research utilizes the ZIF‐8 for the encapsulation and intracellular delivery of nucleic acids, specifically mRNA, for applications in gene delivery. Integrating PEI addresses the issue of mRNA leakage from ZIF‐8, resulting in the delivery and expression of green fluorescent protein (GFP) in vitro and firefly luciferase in vivo.
Harrison Douglas Lawson, Huy Hoang Nguyen, Keng‐Jung Lee, Nattarat Wongsuwan, Ayesha Tupe, Mengrou Lu, Mariah Lynn Arral, Anne Behre, Zihan Ling, Kathryn Ann Whitehead, Adam Walter Feinberg, Xi Ren, Si‐Yang Zheng   +12 more
wiley   +1 more source

Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo [PDF]

A Mangia, Andreas R Günthert, BC Tarlatzis, C Gründker, C Gründker, C Gründker, C Gründker, C Gründker, Carsten Gründker, Crispin Föst, D Weckermann, DL Olive, F Labrie, F Olivennes, G Emons, G Emons, G Emons, G Emons, G Emons, G Griesinger, G Irmer, G Konecny, Günter Emons, H Al-Inany, J Ferlay, JF Robertson, KH Baumann, KR Bauer, LM Mooney, M Dobkin-Bekman, M Fekete, MJ Kim, N Eicke, Nadine Nolte, O Gluz, R Dent, R Sharma, RL Barbieri, RL Barbieri, RU Jänicke, S Fister, S Fister, SJ Dawson, Stefanie Fister, T Moriya, TO Nielsen, VS Cardone   +46 more
core   +1 more source

Exercise Communication for Breast Cancer Survivors: A Systematic Scoping Review.

JAMA Netw Open
Wilson OWA, Wojcik KM, Jayasekera J, Rogers LQ, Demark-Wahnefried W, Farrell D, Butera G, Matthews CE, Street RL.   +8 more
europepmc   +1 more source

The shared genetic landscape of polycystic ovary syndrome and breast cancer: convergence on ER + breast cancer but not ER- breast cancer. [PDF]

Breast Cancer Res
Bi K, Chen M, Zhao Q, Yang T, Xie W, Ma W, Jia H.   +6 more
europepmc   +1 more source

3D Bioprinted Head and Neck Squamous Cell Carcinoma (HNSCC) Model Using Tunicate Derived Nanocellulose (NC) Bioink

Advanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
A 3D bioprinted HNSCC model for use in anti‐cancer drug testing is established in proof‐of‐concept. The innovative tunicate‐derived nanocellulose hydrogel proved to be a viable alternative to gelatin‐based hydrogel, offering improved bioprintability for HNSCC model establishment.
Alexya Azhakesan, Johann Kern, Ankit Mishra, Christine Selhuber‐Unkel, Annette Affolter, Paul Gatenholm, Nicole Rotter, Karen Bieback   +7 more
wiley   +1 more source

Advances in mRNA vaccine therapy for breast cancer research. [PDF]

Discov Oncol
Li JY, Jiang RY, Wang J, Wang XJ.
europepmc   +1 more source

“Therapies Through Gut:” Targeted Drug Delivery for Non‐Gastrointestinal Diseases by Oral Administration

Advanced Healthcare Materials, EarlyView.
Schematic illustration of the mechanism of targeted delivery of nanoparticles including 1) paracellular, 2) endolysosomal escape, 3) receptor mediated endocytosis, and 4) M cell mediated transport for non‐GI diseases by oral administration such as atherosclerosis, cancer, diabetes, and brain diseases. Abstract Oral drug delivery is a promising approach
Subarna Ray, Shehzahdi S. Moonshi, Hang Thu Ta   +2 more
wiley   +1 more source

Oxytocin receptor and HER2 interactions in breast cancer

Liu H, Liu L, Möller A, Muttenthaler M.
europepmc   +1 more source